Research Progress in Patent Foramen Ovale and Cryptogenic Stroke

Abstract

Abstract:

Cryptogenic stroke is through a comprehensive screening, but still 40% of the stroke can not find a clear etiology. Patent foramen ovale may result in paradoxical embolism which will lead to stroke attack. In recent years, we found that some of the cryptogenic stroke may be cause by patent foramen ovale. This article will introduce the research status of inspection methods, mechanism and therapy of patent foramen ovale and cryptogenic stroke.

Key words: Patent foramen ovale; Cryptogenic stroke; Ultrasonic; Therapy

摘要：

经过全面筛查，仍有约40%找不到明确病因的缺血性卒中为隐源性卒中。卵圆孔未闭可引起反常栓塞，进而发生缺血性卒中。近年来发现，部分隐源性卒中可能由卵圆孔未闭导致。本文将从检查方法、作用、机制及治疗等方面对卵圆孔未闭与隐源性卒中的研究现状进行介绍。

关键词: 卵圆孔未闭; 隐源性卒中; 超声; 治疗

YAN Jin-Hong, LI Guo-Zhong. Research Progress in Patent Foramen Ovale and Cryptogenic Stroke[J]. Chinese Journal of Stroke, 2015, 10(12): 1049-1053.

闫金红，李国忠. 卵圆孔未闭与隐源性卒中的研究进展[J]. 中国卒中杂志, 2015, 10(12): 1049-1053.

References

1 Finsterer J. Management of cryptogenic stroke[J].

Acta Neurol Belg, 2010, 110:135-147.

2 Hara H, Virmani R, Ladich E, et al. Patent foramen

ovale:current pathology, pathophysiology, and clinical

status[J]. J Am Coll Cardiol, 2005, 46:1768-1776.

3 Komar M, Podol e c P, P r zewlock i T, e t a1.

Transoesophageal echocardiography can help

distinguish between patients with “symptomatic” and

“asymptomatic” patent foramen ovale[J]. Kardiol Pol,

2012, 70:1258-1263.4 Rana BS, Shapi ro LM, McCar thy KP, e t a l .

Threedimensional imaging of the atrial septum

and patent foramen ovale anatomy:defining the

morphological phenotypes of patent foramen ovale[J].

Eur J Echocardiogr, 2010, 11:i19-25.

5 Tanaka J, Izumo M, Fukuoka Y, et al. Comparison of

two-dimensional versus real-time three-dimensional

transesophageal echocardiography for evaluation of

patent foramen ovale morphology[J]. Am J Cardiol,

2013, 111:1052-1056.

6 Cot t e r PE, Ma r t i n PJ, Bel ham M. Towa rd

understanding the atrial septum in cryptogenic

stroke[J]. Int J Stroke, 2011, 6:445-453.

7 Maffè S, Dellavesa P, Zenone F, et al. Transthoracic

second harmonic two-and th ree-dimensional

echocardiography for detection of patent foramen

ovale[J]. Eur J Echocardiogr, 2010, 11:57-63.

8 Hamilton-Craig C, Sestito A, Natale L, et al. Contrast

transoesophageal echocardiography remains superior

to contrast-enhanced cardiac magnetic resonance

imaging for the diagnosis of patent foramen ovale[J].

Eur J Echocardiogr, 2011, 12:222-227.

9 Kim YJ, Hur J, Shim CY, et al. Patent foramen

ovale:diagnosis with multidetector CT-comparison

with transesophageal echocardiography[J]. Radiology,

2009, 250:61-67.

10 Amarenco P, Bogousslavsky J, Caplan LR, et al.

Classification of stroke subtypes[J]. Cerebrovasc Dis,

2009, 27:493-501.

11 Amin H, Greer DM. Cryptogenic st roke-the

appropriate diagnostic evaluation[J]. Curr Treat

Options Cardiovasc Med, 2014, 16:280.

12 Frei l inger TM, Schindler A, Schmidt C, e t

al. Prevalence of nonst enosing, complicated

atherosclerotic plaques in cryptogenic stroke[J]. JACC

Cardiovasc Imaging, 2012, 5:397-405.

13 Johnson BI. Paradoxical embolism[J]. J Clin Pathol,

1951, 4:316-332.

14 Lippi G, Favaloro EJ, Franchini M. Paradoxical

thrombosis par t 1:factor replacement therapy,

inherited clotting factor deficiencies and prolonged

APTT[J]. J Thromb Thrombolysis, 2012, 34:360-366.

15 Sandler DA, Martin JF. Autopsy proven pulmonary

embolism in hospital patients:are we detecting enough

deep vein thrombosis?[J]. JR Soc Med, 1989, 82:203-205.

16 Cramer SC, Rordorf G, Maki JH, et al. Increased

pelvic vein thrombi in cryptogenic stroke:results of

the Paradoxical Emboli from Large Veins in Ischemic

Stroke (PELVIS) study[J]. Stroke, 2004, 35:46-50.

17 Palareti G, Schellong S. Isolated distal deep vein

thrombosis:what we know and what we are doing[J].J Thromb Haemost, 2012, 10:11-19.

18 Lehmeyer S, Lindhoff-Last E. New aspects of

paradoxical embolism[J]. Vasa, 2011, 40:31-40.

19 Spies C, Wong M. Patent foramen ovale and

cryptogenic stroke:a complex neuro-cardio-vascular

problem [J]. Expert Rev Cardiovasc Ther, 2009,

7:1455-1467.

20 Nendaz MR, Sarasin FP, Junod AF, et al. Preventing

stroke recurrence in patients with patent foramen

ovale:antithrombotic therapy, foramen closure,

or therapeutic abstention? A decision analytic

perspective[J]. Am Heart J, 1998, 135:532-541.

21 Mohr JP, Thompson JL, La za r RM et a l. A

comparison of warfarin and aspirin for the prevention

of recurrent ischemic stroke[J]. N Engl J Med, 2001,

345:1444-1451.

22 Shar iat A, Yaghoubi E, Farazdaghi M, et al.

Comparison of medical treatments in cryptogenic

st roke pat ients with patent foramen ovale:A

randomized clinical trial[J]. J Res Med Sci, 2013,

18:94-98.

23 Fischer D, Gardiwal A, Haentjes J, et al. Sustained risk

of recurrent thromboembolic events in patients with

patent foramen ovale and paradoxical embolism:longterm

follow-up over more than 15 years[J]. Clin Res

Cardiol, 2012, 101:297-303.

24 Ning M, Lo EH, Ning PC, et al. The brain's heartJ Thromb Haemost, 2012, 10:11-19.

18 Lehmeyer S, Lindhoff-Last E. New aspects of

paradoxical embolism[J]. Vasa, 2011, 40:31-40.

19 Spies C, Wong M. Patent foramen ovale and

cryptogenic stroke:a complex neuro-cardio-vascular

problem [J]. Expert Rev Cardiovasc Ther, 2009,

7:1455-1467.

20 Nendaz MR, Sarasin FP, Junod AF, et al. Preventing

stroke recurrence in patients with patent foramen

ovale:antithrombotic therapy, foramen closure,

or therapeutic abstention? A decision analytic

perspective[J]. Am Heart J, 1998, 135:532-541.

21 Mohr JP, Thompson JL, La za r RM et a l. A

comparison of warfarin and aspirin for the prevention

of recurrent ischemic stroke[J]. N Engl J Med, 2001,

345:1444-1451.

22 Shar iat A, Yaghoubi E, Farazdaghi M, et al.

Comparison of medical treatments in cryptogenic

st roke pat ients with patent foramen ovale:A

randomized clinical trial[J]. J Res Med Sci, 2013,

18:94-98.

23 Fischer D, Gardiwal A, Haentjes J, et al. Sustained risk

of recurrent thromboembolic events in patients with

patent foramen ovale and paradoxical embolism:longterm

follow-up over more than 15 years[J]. Clin Res

Cardiol, 2012, 101:297-303.

24 Ning M, Lo EH, Ning PC, et al. The brain's hearttherapeutic

oppor tunit ies for patent foramen

ovale(PFO) and neurovascular disease[J]. Pharmacol

Ther, 2013, 139:111-123.

25 Calvet D, Mas JL. Closure of patent foramen ovale in

cryptogenic stroke:a never ending story[J]. Curr Opin

Neurol, 2014, 27:13-19.

26 Thaler DE, Kent DM. Rethinking trial strategies for

stroke and patent foramen ovale[J]. Curr Opin Neurol,

2010, 23:73-78.

27 Furlan AJ, Reisman M, Massaro J, et al. Closure or

medical therapy for cryptogenic stroke with patent

foramen ovale[J]. N Engl J Med, 2012, 366:991-999.

28 Meier B, Kalesan B, Mattle HP, et al. Percutaneous

closure of patent foramen ovale in cryptogenic

embolism[J]. N Engl J Med, 2013, 368:1083-1091.

29 Carroll JD, Saver JL, Thaler DE, et al. Closure

of patent foramen ovale versus medical therapy

after cryptogenic stroke[J]. N Engl J Med, 2013,

368:1092-1100.

30 Windecker S, Meier B. Is closure recommended for

patent foramen ovale and cryptogenic stroke? patent

foramen ovale and cryptogenic stroke:to close or not

to close? Closure:what else![J]. Circulation, 2008,

118:1989-1998.

31 Sanna T, Diener HC, Passman RS, et al. Crytptogenic

stroke and underlying atrial fibrillation[J]. N Engl J

Med, 2014, 370:2478-2486.

[1]	ZHU Jiaqian, CAO Liming. Research Progress of the Diagnostic Methods and Techniques for Patent Foramen Ovale [J]. Chinese Journal of Stroke, 2024, 19(9): 991-997.
[2]	FU Pengcheng, CAO Liming, ZHU Jiaqian, ZHAO Guiyu, XU Gelin. Research Progress of Reperfusion Therapy for Large Artery Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1004-1011.
[3]	ZHANG Liping, CAO Liming, XIAO Nan, LIAO Yuqi, CHI Feng, YU Yanni, REN Lijie. Research Progress and Challenges of Nanomaterials in the Diagnosis and Treatment of Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1012-1017.
[4]	ABULANIYAZI Anaguli, WU Xiaoxin, LI Jiaoxing, LI Zhuhao, SHENG Wenli. Research Progress on Factors Related to the Susceptibility Vessel Sign and its Clinical Application in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(9): 1077-1085.
[5]	GUO Shuaiwei, ZHANG Ya’nan, WANG Shuo. The Status and Significance of Platelet Function Tests in the Assessment of Hemostatic Function in Neurosurgery [J]. Chinese Journal of Stroke, 2024, 19(7): 848-853.
[6]	HAO Manjun, WANG Liyuan, XIONG Yunyun. Neuroimaging Evaluation of Reperfusion Therapy [J]. Chinese Journal of Stroke, 2024, 19(4): 459-467.
[7]	YAN Xige, WANG Guoling, ZHANG Bogang, PENG Min, DONG Zhongjun, SHEN Xiaoping, CHEN Xiuxiao, JIA Qian, DONG Huige, CHENG Li. A Rescue Therapy for Vascular Reocclusion after Carotid Artery Stenting for Acute Carotid Artery Occlusion—Femoral-Carotid Artery Bypass [J]. Chinese Journal of Stroke, 2024, 19(3): 331-336.
[8]	LIANG Xiaoxue, GUO Li. Obesity-Related Chronic Inflammation and Cerebro-Metabolic Disease [J]. Chinese Journal of Stroke, 2024, 19(2): 138-144.
[9]	MO Chenglong, WANG Simin, HOU Le, PENG Liebiao, WANG Rongfei, SHI Haishan, ZHENG Dong. Cerebral Venous Sinus Thrombosis Associated with Hyperthyroidism: A Case Report [J]. Chinese Journal of Stroke, 2024, 19(2): 207-212.
[10]	YANG Zijian, FANG Wei, ZHAO Zhenwei, ZHANG Tao, LUO Guoqiang, XING Zifei, LIU Haitao, GUO Xing, DENG Jianping. Safety and Efficacy of Different Approaches for the Interventional Therapy of Cavernous Sinus Dural Arteriovenous Fistula [J]. Chinese Journal of Stroke, 2024, 19(11): 1288-1295.
[11]	LU Qingli, LIU Pei, SUN Chao, SHI Yaling, LIN Xuemei, WU Songdi. A Case Report of Hypertensive Retinopathy Combined with Posterior Reversible Encephalopathy Syndrome [J]. Chinese Journal of Stroke, 2024, 19(11): 1301-1305.
[12]	YANG Jiajie, ZHANG Liang, HUANG Li’an. Advances in Pharmacogenomics-Based Individualized Antithrombotic Therapy for Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2024, 19(10): 1111-1117.
[13]	XIE Yaoyi, HUANG Yanju, FAN Min, CEN Huatao, LI Yanli, LU Miaozhi, LU Boan, WEI Rangfang, WU Zhiwu. Study on the Clinical Efficacy of Antiplatelet Therapy Guided by CYP2C19 Gene Detection in Ischemic Stroke Patients of Different Ethnic Groups [J]. Chinese Journal of Stroke, 2024, 19(10): 1119-1124.
[14]	HOU Yuting, LI Tong. A Case Report of Dual Antiplatelet Therapy for Acute Basilar Artery Occlusion Based on Rapid CYP2C19 Gene Detection [J]. Chinese Journal of Stroke, 2024, 19(10): 1125-1130.
[15]	WANG Jing, LI Zixiao, DONG Qiang, ZHAO Xingquan. Interpretation of Medical Quality Control Indicators for Intracerebral Hemorrhage [J]. Chinese Journal of Stroke, 2024, 19(1): 50-54.